Shpakov A O, Derkach K V
Zh Evol Biokhim Fiziol. 2015 Jan-Feb;51(1):11-6. doi: 10.1134/s0022093015010020.
One of the approaches to creating the regulators of G-protein-coupled receptors (GPCR) is the development of peptides that structurally correspond to the functionally important regions of the intracellular extracellular loops of the receptors. GPCR-peptides can selectively regulate the functional activity of homologous receptor and affect the hormonal signal transduction via the receptor. Among the peptides corresponding to the intracellular regions of GPCR, their derivatives modified with hydrophobic radicals exhibit the highest activity and selectivity of action in vitro and in vivo. Ample evidence demonstrates that lipophilic GPCR-peptides may be used to treat diseases and various abnormalities that depend on the functional activity of receptors homologous to them. In turn, the peptides corresponding to the extracellular regions of GPCR can be used as functional probes for studying the specific interaction between the receptors and their ligands, as well as for studying the etiology and pathogenesis of autoimmune diseases caused by the production of antibodies to GPCR antigenic determinants that are localized in the receptor extracellular loops. The present review focuses on the recent achievements in development and application of GPCR-peptides and on the prospects for their further use in medicine and fundamental biology.
创建G蛋白偶联受体(GPCR)调节剂的方法之一是开发在结构上与受体细胞内外环功能重要区域相对应的肽。GPCR肽可以选择性地调节同源受体的功能活性,并通过该受体影响激素信号转导。在与GPCR细胞内区域相对应的肽中,用疏水基团修饰的其衍生物在体外和体内表现出最高的活性和作用选择性。大量证据表明,亲脂性GPCR肽可用于治疗依赖于与其同源的受体功能活性的疾病和各种异常情况。反过来,与GPCR细胞外区域相对应的肽可作为功能探针,用于研究受体与其配体之间的特异性相互作用,以及研究由针对位于受体细胞外环中的GPCR抗原决定簇产生抗体所引起的自身免疫性疾病的病因和发病机制。本综述重点关注GPCR肽开发与应用的最新成果以及它们在医学和基础生物学中进一步应用的前景。